Compare Novartis AG (NVS) vs Full Truck Alliance Co. Ltd. American Depositary Shares (each representing 20 Class A Ordinary Shares) (YMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Full Truck Alliance Co. Ltd. American Depositary Shares (each representing 20 Class A Ordinary Shares) — how do they compare? Novartis AG trades at $150.89 (market cap $279.90B), while Full Truck Alliance Co. Ltd. American Depositary Shares (each representing 20 Class A Ordinary Shares) trades at $8.66 (market cap $8.86B). The key difference: Novartis AG is far larger — about 31.6× Full Truck Alliance Co. Ltd. American Depositary Shares (each representing 20 Class A Ordinary Shares)'s market cap, and Full Truck Alliance Co. Ltd. American Depositary Shares (each representing 20 Class A Ordinary Shares) pays the higher dividend (3.93%). Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and Full Truck Alliance Co. Ltd. American Depositary Shares (each representing 20 Class A Ordinary Shares) for 0 Days on average.
| NVS | YMM | |
|---|---|---|
Market Cap | $279.90B | $8.86B |
Volume | 1,647,300 | 9,144,588 |
Sector | Health | Technology |
52-Week High | $168.62 | $13.30 |
52-Week Low | $121.80 | $7.54 |
Typical Hold Time | 82 Days | 0 Days |
Enterprise Value | $321.22B | $5.34B |
Dividend Yield | 3.23% | 3.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $142.41, down 0.99% on the day, with a bearish technical signal and mixed earnings history. The company maintains strong profitability with a net income margin of 22.5% and ROE of 30.55%, though recent clinical trial setbacks and a $7.8 billion licensing deal with China's Abogen highlight strategic shifts. Cash flow from operations remains robust at $19.14 billion for 2025, supporting ongoing investments.
The outlook is cautious; analyst consensus is a 'Hold' with a $146 price target, reflecting concerns over pipeline execution despite solid fundamentals. Key risks include drug trial failures and regulatory scrutiny, while the current valuation at a P/E of 22.19 offers moderate appeal amid sector volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Full Truck Alliance Co. Ltd. American Depositary Shares (each representing 20 Class A Ordinary Shares)
Full Truck Alliance Co. Ltd. operates a digital freight-matching platform in China, connecting shippers with truckers for cargo transport across varying distances and load types.
Read more on YMM →
